Growth Hormone Deteriorates the Functional Outcome in an Experimental Model of Huntington’s Disease Induced by 3-Nitropionic Acid

Background and Purpose: Growth hormone (GH) has been frequently used to control the aging process in healthy individuals, probably due to its slowing effect on senescence-associated degeneration. Mitochondrial dysfunction is related to the aging process, and one of the chemical models of Huntington’...

Full description

Bibliographic Details
Main Authors: Jung-Eun Park, Soon-Tae Lee, Woo-Seok Im, Manho Kim
Format: Article
Language:English
Published: Korean Movement Disorders Society 2013-10-01
Series:Journal of Movement Disorders
Subjects:
Online Access:http://e-jmd.org/upload/jmd-6-2-28-2.pdf
id doaj-b13ad63bba4e47edbd754b7dacf6caf4
record_format Article
spelling doaj-b13ad63bba4e47edbd754b7dacf6caf42020-11-24T23:02:10ZengKorean Movement Disorders SocietyJournal of Movement Disorders2005-940X2093-49392013-10-0162283310.14802/jmd.1300720Growth Hormone Deteriorates the Functional Outcome in an Experimental Model of Huntington’s Disease Induced by 3-Nitropionic AcidJung-Eun ParkSoon-Tae LeeWoo-Seok ImManho KimBackground and Purpose: Growth hormone (GH) has been frequently used to control the aging process in healthy individuals, probably due to its slowing effect on senescence-associated degeneration. Mitochondrial dysfunction is related to the aging process, and one of the chemical models of Huntington’s disease is that it can be induced by mitochondrial toxin. To investigate the potential application of GH to modify the progression of Huntington’s disease (HD), we examined whether GH can protect the functional deterioration by striatal damage induced by 3-nitropropionic acid (3NP). Methods: 3NP (63 mg/kg/day) was delivered to Lewis rats by osmotic pumps for five consecutive days, and the rats received intraperitoneal administration of GH or vehicle (saline) throughout the experiment. Neurological deficits and body weight were monitored. A 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) test was performed to further determine the mitochondrial activity in cultured N18TG2 neuroblastoma cells in vitro. Results: 3NP-treated rats showed progressive neurologic deficits with striatal damage. Application of GH accelerated behavioral deterioration, particularly between day 3 and day 5, resulting in reduced survival outcome. The body weights of rats given 3NP were decreased, but GH did not affect such decrease compared to the non-treated control group. The effect of GH on cultured neuronal cells was a decrease in the MTT absorbance, suggesting a lower number of cells in a dose dependent pattern. Conclusions: Those results suggest that application of GH to a 3NP-induced experimental model of HD deteriorates the progress of functional deficits, possibly disturbing mitochondrial activities.http://e-jmd.org/upload/jmd-6-2-28-2.pdfGrowth hormone3-nitropropionic acidHuntington’s diseaseMitochondria
collection DOAJ
language English
format Article
sources DOAJ
author Jung-Eun Park
Soon-Tae Lee
Woo-Seok Im
Manho Kim
spellingShingle Jung-Eun Park
Soon-Tae Lee
Woo-Seok Im
Manho Kim
Growth Hormone Deteriorates the Functional Outcome in an Experimental Model of Huntington’s Disease Induced by 3-Nitropionic Acid
Journal of Movement Disorders
Growth hormone
3-nitropropionic acid
Huntington’s disease
Mitochondria
author_facet Jung-Eun Park
Soon-Tae Lee
Woo-Seok Im
Manho Kim
author_sort Jung-Eun Park
title Growth Hormone Deteriorates the Functional Outcome in an Experimental Model of Huntington’s Disease Induced by 3-Nitropionic Acid
title_short Growth Hormone Deteriorates the Functional Outcome in an Experimental Model of Huntington’s Disease Induced by 3-Nitropionic Acid
title_full Growth Hormone Deteriorates the Functional Outcome in an Experimental Model of Huntington’s Disease Induced by 3-Nitropionic Acid
title_fullStr Growth Hormone Deteriorates the Functional Outcome in an Experimental Model of Huntington’s Disease Induced by 3-Nitropionic Acid
title_full_unstemmed Growth Hormone Deteriorates the Functional Outcome in an Experimental Model of Huntington’s Disease Induced by 3-Nitropionic Acid
title_sort growth hormone deteriorates the functional outcome in an experimental model of huntington’s disease induced by 3-nitropionic acid
publisher Korean Movement Disorders Society
series Journal of Movement Disorders
issn 2005-940X
2093-4939
publishDate 2013-10-01
description Background and Purpose: Growth hormone (GH) has been frequently used to control the aging process in healthy individuals, probably due to its slowing effect on senescence-associated degeneration. Mitochondrial dysfunction is related to the aging process, and one of the chemical models of Huntington’s disease is that it can be induced by mitochondrial toxin. To investigate the potential application of GH to modify the progression of Huntington’s disease (HD), we examined whether GH can protect the functional deterioration by striatal damage induced by 3-nitropropionic acid (3NP). Methods: 3NP (63 mg/kg/day) was delivered to Lewis rats by osmotic pumps for five consecutive days, and the rats received intraperitoneal administration of GH or vehicle (saline) throughout the experiment. Neurological deficits and body weight were monitored. A 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) test was performed to further determine the mitochondrial activity in cultured N18TG2 neuroblastoma cells in vitro. Results: 3NP-treated rats showed progressive neurologic deficits with striatal damage. Application of GH accelerated behavioral deterioration, particularly between day 3 and day 5, resulting in reduced survival outcome. The body weights of rats given 3NP were decreased, but GH did not affect such decrease compared to the non-treated control group. The effect of GH on cultured neuronal cells was a decrease in the MTT absorbance, suggesting a lower number of cells in a dose dependent pattern. Conclusions: Those results suggest that application of GH to a 3NP-induced experimental model of HD deteriorates the progress of functional deficits, possibly disturbing mitochondrial activities.
topic Growth hormone
3-nitropropionic acid
Huntington’s disease
Mitochondria
url http://e-jmd.org/upload/jmd-6-2-28-2.pdf
work_keys_str_mv AT jungeunpark growthhormonedeterioratesthefunctionaloutcomeinanexperimentalmodelofhuntingtonsdiseaseinducedby3nitropionicacid
AT soontaelee growthhormonedeterioratesthefunctionaloutcomeinanexperimentalmodelofhuntingtonsdiseaseinducedby3nitropionicacid
AT wooseokim growthhormonedeterioratesthefunctionaloutcomeinanexperimentalmodelofhuntingtonsdiseaseinducedby3nitropionicacid
AT manhokim growthhormonedeterioratesthefunctionaloutcomeinanexperimentalmodelofhuntingtonsdiseaseinducedby3nitropionicacid
_version_ 1725637113719816192